BRPF1 and hepatocellular carcinoma: Moreover, inhibition of BRPF1 by CRISPR KO or treatment with BRPF1 bromodomain specific inhibitor GSK5959 inhibited HCC growth in vivo demonstrating that BRPF1s′ bromodomain specific functions are essential determinants of HCC tumorigenesis (32).